Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

A rapid genotyping method for the vitamin K epoxide reductase complex subunit 1 (VKORC1) gene.

Hatch E, Sconce EA, Daly AK, Kamali F.

J Thromb Haemost. 2006 May;4(5):1158-9. No abstract available.

2.

[Vitamin K epoxide reductase: Fresh blood for oral anticoagulant therapies].

Loriot MA, Beaune P.

Rev Med Interne. 2006 Dec;27(12):979-82. Epub 2006 Oct 11. Review. French.

PMID:
17070618
3.

VKORC1 and the vitamin K cycle.

Garcia AA, Reitsma PH.

Vitam Horm. 2008;78:23-33. doi: 10.1016/S0083-6729(07)00002-7. Review.

PMID:
18374188
4.

[Oral anticoagulation and pharmacogenetics: importance in the clinical setting].

Benusiglio PR, Desmeules J, de Moerloose P, Dayer P.

Rev Med Suisse. 2007 Sep 12;3(124):2030, 2033-4, 2036. Review. French.

PMID:
17955831
5.

Vitamin K epoxide reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle.

Oldenburg J, Bevans CG, Müller CR, Watzka M.

Antioxid Redox Signal. 2006 Mar-Apr;8(3-4):347-53. Review.

PMID:
16677080
6.

Pharmacogenetics-based coumarin therapy.

Gage BF.

Hematology Am Soc Hematol Educ Program. 2006:467-73. Review.

PMID:
17124101
7.

[Pharmacogenetics of oral anticoagulants: individualized drug treatment for more efficacy and safety].

Loriot MA, Beaune P.

Rev Prat. 2007 Jun 30;57(12):1281-6. Review. French.

PMID:
17717937
8.

Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives.

Yin T, Miyata T.

Thromb Res. 2007;120(1):1-10. Epub 2006 Dec 11. Review.

PMID:
17161452

Supplemental Content

Support Center